Skip to main content

Neurodegenerative Disease clinical trials at UCSF

2 research studies open to eligible people

Showing trials for
  • AMX0035 and Progressive Supranuclear Palsy

    open to eligible people ages 40-80

    ORION Trial is a trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of a randomized double blind placebo controlled phase, followed by an optional open-label extension phase.

    San Francisco, California and other locations

  • Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research

    open to eligible people ages 18 years and up

    The overall goal of this project is to identify, assess and longitudinally monitor subjects who are interested in participating in brain research. Participants will enroll through the website,, and provide informed consent prior to any study activities. The website will collect a variety of information, including participants' overall health, memory complaints, family history of dementia and Alzheimer's disease (AD), mood status, sleep, diet, and exercise-all through self-reported online questionnaires. Participants will also be ask to take online cognitive tests, and to return to the website at regular intervals, to complete follow-up questionnaires and neuropsychological assessments. Everyone over the age of 18 is welcome to participate. To join the Brain Health Registry, please visit

    San Francisco, California

Our lead scientists for Neurodegenerative Disease research studies include .

Last updated: